Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis [Phase 2]
Phase 2 double-blind, randomized, placebo-controlled trial of CC-10004 in moderate-to-severe plaque psoriasis completed.
-
EMA withdrawal · 2020-03-25EMA Withdrawn: Kromeya (adalimumab) — Fresenius Kabi Deutschland GmbH
EMA has withdrawn Kromeya (adalimumab) from Fresenius Kabi Deutschland GmbH, effective 2019, affecting multiple inflammatory diseases.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis [Phase 2]
Phase 2 trial evaluating two doses of apremilast (CC-10004) in Japanese patients with moderate-to-severe plaque-type psoriasis; study comple…
-
FDA approval · 2020-03-04FDA Approved: HYDROCORTISONE VALERATE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved the original application for hydrocortisone valerate by Cosette Pharmaceuticals, Inc., establishing a new generic topical corti…
-
EMA withdrawal · 2020-02-20EMA Lapsed: Lifmior (etanercept) — Pfizer Europe MA EEIG
The European Medicines Agency indicates Lifmior (etanercept) has lapsed; the product is no longer active in the market for its indicated con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-02-10FDA Approved: FLUOCINONIDE — Original Application (Zydus Lifesciences Limited)
The FDA approved the original application for a generic fluocinolone topical product from Zydus Lifesciences Limited. The approval confirms …
-
FDA approval · 2020-01-30FDA Approved: METHOTREXATE — Original Application (Chartwell RX, LLC)
FDA approvedChartwell RX, LLC's methotrexate product under an Original Application, making a new generic version of methotrexate available. …
-
FDA approval · 2019-12-30FDA Approved: CLOBETASOL PROPIONATE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved an original application for clobetasol propionate topical from Torrent Pharmaceuticals Limited (generic).
-
FDA approval · 2019-12-18FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved an original application for Betamethasone dipropionate by Lupin Pharmaceuticals, Inc., granting a generic topical corticosteroi…
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
Observational post-marketing study assessing AbbVie's Humira effectiveness in psoriasis completed with results posted in 2019.
-
FDA approval · 2019-11-29FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Encube Ethicals, Inc.)
The FDA approved Encube Ethicals' Triamcinolone Acetonide Ointment USP, 0.05% as an original generic topical corticosteroid product through …
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients [Phase 2]
Phase 2 trial update showing initial dosing of BI 655130 in patients with palmoplantar pustulosis (a form of psoriasis); results have been p…
-
FDA approval · 2019-11-26FDA Approved: FLUOCINONIDE — Original Application (Xiromed LLC)
FDA approved the original application for fluocinonide (topical corticosteroid) submitted by Xiromed LLC.
-
FDA approval · 2019-11-15FDA Approved: CLOBETASOL PROPIONATE — Original Application (Encube Ethicals, Inc.)
FDA approved the Original Application for Clobetasol Propionate Ointment USP, 0.05% (generic) by Encube Ethicals, Inc.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Using an Internet Study to Improve Adherence for Psoriasis Patients [EARLY_Phase 1]
Phase 1 trial exploring an internet-based approach to improve adherence in psoriasis patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)
Post-marketing observational study evaluating the impact of AbbVie's Patient Support Program on patient-reported outcomes and health resourc…
-
FDA approval · 2019-11-05FDA Approved: CALCIPOTRIENE — Supplemental Application (Mayne Pharma)
The FDA approved a supplemental application for CALCIPOTRIENE submitted by Mayne Pharma. The document does not specify the exact changes inc…
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of MC2-01 Cream for psoriasis has completed, with results posted in October 2019…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis [Phase 1, Phase 2]
Clinical trial update for BMS-986251 (oral) in healthy participants and patients with psoriasis and rheumatoid arthritis; study terminated w…
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Psoriasis、Indigo Naturalis、Chinese Medicine Medicated Bath [Phase 2]
Phase 2 clinical trial update involving Indigo Naturalis and Chinese medicine medicated bath for psoriasis.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis
A completed clinical trial evaluating the safety and effectiveness of etanercept for pediatric psoriasis with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis [Phase 3]
Phase 3 trial comparing guselkumab to secukinumab for moderate to severe plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Psoriasis-Arthritis & Bone Program [Phase 2]
Phase 2 clinical trial update for a psoriasis-arthritis and bone program completed, investigating treatments for psoriasis and psoriatic art…
-
FDA approval · 2019-09-24FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Lifesciences Limited)
FDA approves the original application for clobetasol propionate topical (generic) by Zydus Lifesciences Limited, adding another generic opti…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Collaborative Connected Health (CCH) for PCORI [NA]
A completed clinical trial on psoriasis conducted by the University of Southern California; results posted in 2019.